Green Cross Holdings Preference Shares (KO:005257) — Market Cap & Net Worth

$2.96 Million USD  · ₩4.38 Billion KRW  · Rank #29579

Market Cap & Net Worth: Green Cross Holdings Preference Shares (005257)

Green Cross Holdings Preference Shares (KO:005257) has a market capitalization of $2.96 Million (₩4.38 Billion) as of September 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #29579 globally and #2091 in its home market, demonstrating a 0.00% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross Holdings Preference Shares's stock price ₩18180.00 by its total outstanding shares 240657 (240.66K). Also see 005257 current and non-current assets for a full breakdown of the balance sheet.

Green Cross Holdings Preference Shares Market Cap History: 2015 to 2026

Green Cross Holdings Preference Shares's market capitalization history from 2015 to 2026. Data shows change from $3.96 Million to $2.96 Million (-1.93% CAGR). Also see how efficiently does Green Cross Holdings Preference Shares generate cash for how efficiently the company converts equity into cash flow.

Green Cross Holdings Preference Shares Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Green Cross Holdings Preference Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Green Cross Holdings Preference Shares for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.00x

Green Cross Holdings Preference Shares's market cap is 0.00 times its annual revenue

Industry average: 3887.01x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $3.22 Million $1.35 Trillion $47.18 Billion 0.00x 0.00x
2017 $4.11 Million $1.46 Trillion $43.36 Billion 0.00x 0.00x
2018 $2.53 Million $1.55 Trillion $18.47 Billion 0.00x 0.00x
2019 $2.85 Million $1.52 Trillion $2.96 Billion 0.00x 0.00x
2020 $20.18 Million $1.72 Trillion $170.96 Billion 0.00x 0.00x
2021 $8.09 Million $1.84 Trillion $55.27 Billion 0.00x 0.00x
2022 $5.32 Million $2.08 Trillion $32.82 Billion 0.00x 0.00x
2023 $5.09 Million $2.06 Trillion -$54.14 Billion 0.00x N/A
2024 $3.86 Million $2.20 Trillion $24.03 Billion 0.00x 0.00x
2025 $4.30 Million $2.45 Trillion -$69.51 Billion 0.00x N/A

Competitor Companies of 005257 by Market Capitalization

Companies near Green Cross Holdings Preference Shares in the global market cap rankings as of September 18, 2026. Review 005257 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Green Cross Holdings Preference Shares by market ranking:

  • Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.09 Billion USD.
  • Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.34 Billion USD.
  • CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.87 Billion USD ( AU$84.62 Billion AUD).
  • Moderna Inc (NASDAQ:MRNA): Ranked #505 globally with a market cap of $54.14 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#187 Vertex Pharmaceuticals Inc NASDAQ:VRTX $130.09 Billion $513.26
#353 Regeneron Pharmaceuticals Inc NASDAQ:REGN $78.34 Billion $774.61
#457 CSL Ltd AU:CSL $59.87 Billion AU$174.41
#505 Moderna Inc NASDAQ:MRNA $54.14 Billion $145.62

Green Cross Holdings Preference Shares Historical Marketcap From 2015 to 2026

Between 2015 and today, Green Cross Holdings Preference Shares's market cap moved from $3.96 Million to $ 2.96 Million, with a yearly change of -1.93%.

Year Market Cap Change (%)
2026 ₩2.96 Million -31.01%
2025 ₩4.30 Million +11.42%
2024 ₩3.86 Million -24.20%
2023 ₩5.09 Million -4.40%
2022 ₩5.32 Million -34.20%
2021 ₩8.09 Million -59.92%
2020 ₩20.18 Million +607.67%
2019 ₩2.85 Million +12.74%
2018 ₩2.53 Million -38.46%
2017 ₩4.11 Million +27.73%
2016 ₩3.22 Million -18.80%
2015 ₩3.96 Million --

End of Day Market Cap According to Different Sources

On Sep 17th, 2026 the market cap of Green Cross Holdings Preference Shares was reported to be:

Source Market Cap
Yahoo Finance $2.96 Million USD
MoneyControl $2.96 Million USD
MarketWatch $2.96 Million USD
marketcap.company $2.96 Million USD
Reuters $2.96 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Green Cross Holdings Preference Shares

KO:005257 Korea Biotechnology
Market Cap
$2.96 Million
₩4.38 Billion KRW
Market Cap Rank
#29579 Global
#2091 in Korea
Share Price
₩18180.00
Change (1 day)
+1.62%
52-Week Range
₩13800.00 - ₩28750.00
All Time High
₩250917.65
About

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more